Viewing Study NCT06045260


Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2026-03-07 @ 3:29 AM
Study NCT ID: NCT06045260
Status: RECRUITING
Last Update Posted: 2024-08-13
First Post: 2023-09-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: "Receptor Radionuclide Therapy With 177Lu-DOTATOC
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neuroendocrine Tumors View
None Paraganglioma View
None Pheochromocytoma View
Keywords: